1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-03-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 12453314 2024-03-01 2025-02-28 12453314 2025-02-28 12453314 2024-02-29 12453314 2023-03-01 2024-02-29 12453314 2024-02-29 12453314 2023-02-28 12453314 bus:Director1 2024-03-01 2025-02-28 12453314 core:WithinOneYear 2025-02-28 12453314 core:WithinOneYear 2024-02-29 12453314 bus:Micro-entities 2024-03-01 2025-02-28 12453314 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 12453314 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12453314 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12453314 bus:FullAccounts 2024-03-01 2025-02-28
COMPANY REGISTRATION NUMBER: 12453314
ALLERGY MED LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
28 February 2025
ALLERGY MED LTD
STATEMENT OF FINANCIAL POSITION
28 February 2025
2025
2024
£
£
£
Fixed assets
1,138
-------
----
Current assets
59,993
48,206
Creditors: amounts falling due within one year
5,710
9,782
--------
--------
Net current assets
54,283
38,424
--------
--------
Total assets less current liabilities
55,421
38,424
Accruals and deferred income
600
600
--------
--------
54,821
37,824
--------
--------
Capital and reserves
54,821
37,824
--------
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 1 August 2025 , and are signed on behalf of the board by:
Dr P L B Chellappan Pillai
Director
Company registration number: 12453314
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 Ambrose Close, Orpington, BR6 9UD, UK.